Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study

被引:3
|
作者
Mester, Alexandru [1 ]
Piciu, Andra [2 ]
Piciu, Doina [3 ]
Petean, Ioan [4 ]
Lucaciu, Patricia Ondine [1 ]
Apostu, Dragos [5 ]
Moisescu-Goia, Cristina [3 ]
Voina-Tonea, Andrada [6 ]
Moldovan, Marioara [7 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Dept Oral Hlth, Cluj Napoca 400012, Romania
[2] Univ Med & Pharm Iuliu Hatieganu, Dept Med Oncol, Cluj Napoca 400012, Romania
[3] Univ Med & Pharm Iuliu Hatieganu, Oncol Inst Ion Chiricuta, Dept Endocrine Tumors & Nucl Med, Cluj Napoca 400012, Romania
[4] Univ Babes Bolyai, Fac Chem & Chem Engn, Cluj Napoca 400294, Romania
[5] Univ Med & Pharm Iuliu Hatieganu, Dept Orthoped, Cluj Napoca 400012, Romania
[6] Univ Med & Pharm Iuliu Hatieganu, Dept Dent Mat, Cluj Napoca 400012, Romania
[7] Univ Babes Bolyai, Inst Chem Raluca Ripan, Dept Polymer Composites, Cluj Napoca 400294, Romania
关键词
oral disease; differentiated thyroid cancer; radioiodine therapy; dental hard tissue; RADIOACTIVE IODINE; ENAMEL; TEETH; MICROHARDNESS;
D O I
10.3390/biomedicines8110475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate, in vitro, the effects of I-131 on enamel and dentin in healthy human incisive permanent maxillary teeth. Our in vitro model analogue with the in vivo conditions of differentiated thyroid carcinoma patients treated with I-131, consisted in a solution of I-131 dissolved in artificial saliva. A total of 48 teeth were divided into eight groups (n = 6): control, irradiation groups at 3, 6, 12, 24, 36, 48, and 192 h, respectively. At the end of radiation exposure, radioiodine activity of specimens was assessed. Fine microstructure, nanostructure, surface roughness, and hidroxyapatite (HAP) crystallite diameter were investigated by atomic force microscopy (AFM) to both enamel and dentin structures. There is a constant increase of radioactivity in dental structures at 3, 6, 12, 24 h, due to progressive retention and I-131 migration, with a maximum at 36 h. Enamel showed notable alterations, which was correlated with the increase of the treatment time. A relevant visible distance between the HAP prisms was observed after 24 h. The surface suffered a loss in its compact structure. I-131 acts in the same way on HAP crystallites in dentin as in those in enamel. It was noticed that their morpho-dimensional changes occurred only after 12 h of treatment. Radioiodine-131 determines degradation of enamel and dentin by starting from the alteration of the crystalline network of HAP prisms, transforming them from compact materials into an agglomeration of rocky submicron structures.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis
    Piciu, Doina
    Bran, Simion
    Moldovan, Marioara
    Varvara, Simona
    Piciu, Andra
    Cuc, Stanca
    Moisescu-Goia, Cristina
    Barbus, Elena
    Mester, Alexandru
    Onisor, Florin
    CANCERS, 2023, 15 (09)
  • [2] Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
    Hong, Chae Moon
    Ahn, Byeong-Cheol
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [3] RADIOIODINE I-131 IN POSTOPERATIVE TREATMENT OF DIFFERENTIATED THYROID CANCER - RESULTS OF A PROSPECTIVE STUDY
    KRISHNAM.GT
    WINSTON, MA
    BLAHD, WH
    JOURNAL OF NUCLEAR MEDICINE, 1973, 14 (06) : 419 - 420
  • [4] Zirconia Implants Indicated Better Stability After Exposure to Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer
    Mester, Alexandru
    Piciu, Doina
    Moldovan, Marioara
    Sarosi, Codruta
    Cuc, Stanca
    Petean, Ioan
    Moisescu-Pop, Cristina
    Piciu, Andra
    Onisor, Florin
    Bran, Simion
    CANCERS, 2025, 17 (04)
  • [5] RADIOIODINE I-131 THERAPY IN MANAGEMENT OF THYROID CANCER - PROSPECTIVE-STUDY
    KRISHNAMURTHY, GT
    BLAHD, WH
    CANCER, 1977, 40 (01) : 195 - 202
  • [6] Factors influencing the dosimetry and the therapeutic outcome of radioiodine (I-131) therapy of differentiated thyroid cancer
    Behr, TM
    Behe, M
    Gratz, S
    Hüfner, M
    Becker, W
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1004 - 1004
  • [7] I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy
    Probst, Stephan
    Abikhzer, Gad
    Chausse, Guillaume
    Tamilia, Michael
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2018, 27 (02) : 84 - 87
  • [8] RADIOIODINE-131 IN THE DIAGNOSIS AND TREATMENT OF METASTATIC WELL DIFFERENTIATED THYROID-CANCER
    MAXON, HR
    SMITH, HS
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (03) : 685 - 718
  • [9] THYROID CANCER AND THERAPY WITH I-131
    PIERS, DA
    LANCET, 1976, 2 (7981): : 373 - 373
  • [10] The influence of I-131 therapy on FDG uptake in differentiated thyroid cancer
    Hung, Guang-Uei
    Lee, Kwo-Whei
    Liao, Pei-Yung
    Yang, Li-Heng
    Yang, Kwang-Tao
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (06) : 481 - 485